Literature DB >> 1117238

Estimation of aldosterone, 11-deoxycorticosterone, 18-hydroxy-11-deoxy-corticosterone, corticosterone, cortisol and 11-deoxycortisol in human plasma by gas-liquid chromatography with electron capture detection.

P A Mason, R Fraser.   

Abstract

A method for determining the plasma concentrations of six major corticosteroids, aldosterone, 18-hydroxy-11-deoxycorticosterone (18-OH-DOC), corticosterone, deoxycorticosterone (DOC), cortisol and 11-deoxycortisol using gas-liquid chromatography with electron capture detection is described. Esterification of suitable derivatives of these compounds with heptafluorobutyric anhydride (HFB) allowed detection of quantitities of steroid, ranging from 0-3 pg for androstenetrione HFB (from cortisol) to 2-3 pg for corticosterone HFB. No detectable reagent blank was obtained for any compound when water was used instead of plasma and this was also the case when plasma from an adrenalectomized subject was analysed, with the exception of 18-OH-DOC where a reproducible but negligibly small blank occurred. Coefficients of variation for replicate determinations ranged from 8% for corticosterone to 17% for aldosterone. Concentrations in a series of normal human plasma samples were as follows: aldosterone, 4-0- 18-0 ng/100 ml; 18-OH-DOC, 20-16- ng/ml; corticosterone, 0-08 - 0.-80 mug/100 ml; DOC, 2-8 - 16-0 ng/100 ml; cortisol, 2-5 - 10-0 mug/100 ml; and 11-deoxycortisol, 40-0 - 400-0 ng/100 ml. When seven normal subjects were treated with dexamethasone concentrations of DOC, cortisol and 11-deoxycortisol fell to below the limit of the normal range, those of 18-OH-DOC and corticosterone were at the lower end of the normal range while the concentration of aldosterone was not significantly affected.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117238     DOI: 10.1677/joe.0.0640277

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

1.  Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol.

Authors:  S Sonkodi; E Agabiti-Rosei; R Fraser; B J Leckie; J J Morton; A M Cumming; V P Sood; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

2.  Studies on the production and action of polymorph migration stimulator.

Authors:  R D Stevenson
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man.

Authors:  J A Millar; K A McLean; D J Sumner; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Familial glucocorticoid deficiency. Studies of diagnosis and pathogenesis.

Authors:  D Thistlethwaite; J A Darling; R Fraser; P A Mason; L H Rees; R A Harkness
Journal:  Arch Dis Child       Date:  1975-04       Impact factor: 3.791

5.  The effects of ACTH on steroid metabolomic profiles in human adrenal cells.

Authors:  Yewei Xing; Michael A Edwards; Clarence Ahlem; Mike Kennedy; Anthony Cohen; Celso E Gomez-Sanchez; William E Rainey
Journal:  J Endocrinol       Date:  2011-03-23       Impact factor: 4.286

6.  Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects.

Authors:  J A Millar; R Fraser; P Mason; B Leckie; A M Cumming; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

7.  Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.

Authors:  J D Baxter; M Schambelan; D T Matulich; B J Spindler; A A Taylor; F C Bartter
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.